2021-11-16-世界卫生组织-Cervical_cancer_Samoa_2021_country_profile_1页_63kb

Cervical Cancer Profile Summary for SAMOA

• Morbidity and Mortality (2019-2020)

  • Age-standardized cervical cancer incidence is reported, with a population-based cancer registry existing.
  • Data on crude incidence, cumulative risk, and mortality-to-incidence ratio are partially or fully available, but specific values not provided.

• Primary Prevention

  • HPV vaccination program has coverage of 20% for first dose but is not included in the national vaccination schedule.
  • Risk factors include tobacco use prevalence of 1.5%, limited condom use data, and HIV incidence not fully available.
  • Program target cohort is 9-14-year-old girls, introduced in 2020 with varying coverage.

• Secondary Prevention Screening

  • No national cervical cancer screening program identified, but primary screening test details are partially outlined.
  • Among women aged 30-49, 36% reported ever having been screened, with 29% in the last 5 years, indicating low screening uptake and inadequate guidelines at primary health care level.

• Treatment and Supportive Care

  • National cervical cancer management guidelines exist, and data on staff and equipment (e.g., radiotherapy units, cancer centers) show limitations.
  • Palliative care is available through the public health system, but specific resources like opioid consumption are dated back to 2017.

• Additional Data

  • WHO Strategy targets not detailed locally.
  • SAMOA has a female population of approximately 95,000, with 590 cervical cancer deaths in 2019.